Human medicines European public assessment report (EPAR): Binocrit, epoetin alfa, Date of authorisation: 28/08/2007, Revision: 25, Status: Authorised

Antimicrobial Sales and Use (ASU) Platform: Release notes

Human medicines European public assessment report (EPAR): Abseamed, epoetin alfa, Date of authorisation: 27/08/2007, Date of refusal: 18/06/2009, Revision: 26, Status: Authorised

SPOR and XEVMPD status update webinar, Broadcast, from 9 April 2025, 10:00 (CEST) to 9 April 2025, 12:30 (CEST)

Q&A extract - SPOR and XEVMPD status update webinar 9 April 2025

Unlocking PMS API potential: Edit functionality training for MAHs, Online, European Medicines Agency, Amsterdam, the Netherlands, from 16 October 2025, 10:00 (CEST) to 16 October 2025, 11:30 (CEST)

PMS PUI Training: Product data submission & bulk edit made easy, Online, European Medicines Agency, Amsterdam, the Netherlands, from 6 October 2025, 10:00 (CEST) to 6 October 2025, 12:00 (CEST)

Human medicines European public assessment report (EPAR): Kayfanda, odevixibat, Date of authorisation: 19/09/2024, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR): Bylvay, odevixibat, Date of authorisation: 16/07/2021, Revision: 11, Status: Authorised

Human medicines European public assessment report (EPAR): Levetiracetam Accord, levetiracetam, Date of authorisation: 03/10/2011, Revision: 20, Status: Authorised